A PROSPECTIVE TRIAL OF IODIXANOL 270, 320 (VISIPAQUE) IN PATIENTS WITH RENAL IMPAIRMENT (WHO HAS SERUM CREATININE BETWEEN 1.8-3.0 MH/DL.) UNDERGOING COMPUTED TOMOGRAPHY AND INTRAVENOUS PYELOGRAPHY

Turney JH. Acute renal failure -- a dangerous condition. JAMA 1996; 275: 1516-1517.

Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264.

Berg KJ. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 2000; 34: 317-322.

Cochran ST, Wong WS, Roe DJ. Predicting angiography-induced acute renal function impairment: clinical risk model. AJR Am J Roentgenol 1983; 141: 1027-1033.

Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Eur Radiol 1999;9:1602 -1613.

Waybill MM, Waybill PN. Contrast media -induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001: 12: 3-9.

Barrett BJ, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41: 1274- 1279.

Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial: the Iohexol Cooperative Study. Kidney Int 1995; 47: 254-261.

Taliercio CP, Vlietstra RE, Ilstrup DM, etal. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol 1991; 17: 384-390.

Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-620.

Wang A, Holcslaw T, Bashore TM, et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 2000; 57: 1675-1680.

Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996; 275: 1489-1494.

McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375.

Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. AJR Am J Roentgenol 1991; 157: 59- 65. [Erratum, AJR Am J Roentgenol 1991; 157: 895.]

Morcos SK. Contrast media-induced nephrotoxicity -- questions and answers. BrJ Radiol 1998; 71: 357-365

Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994; 45: 259-265.

Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 1989; 320: 143-149.

Schwab SJ, Hlatky MA, Pieper KS, et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 989; 320: 149-153.

Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5: 125-137.

Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low -osmolality iodinated contrast media. Radiology 1993; 188: 171-178.

Grynne BH, Nossen JO, Bolstad B, Borch KW. Main results of the first comparative clinical studies on Visipaque. Acta Radiol Suppl 1995; 399: 265-270.

Jakobsen JA. Renal experience with Visipaque. Eur Radiol 1996; 6: Suppl 2: S16-S19.

Davidson CJ, Laskey WK, Hermilller JB, et al. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation 2000; 101: 2172-2177.

Murakami R, Tajima H, Kumazaki T, Yamamoto K. Effect of iodixanol on renal function immediately after abdominal angiography: clinical comparison with iomeprol and ioxaglate. Acta Radiol 1998; 39: 368-371.